Shopping Cart

Remove All
Your shopping cart is currently empty

R 59-022

Name: R 59-022
Brand: TargetMol
SKU: T16709
Price: 32 USD
Availability: InStock
Rating: 5 (10 reviews)

🥰Excellent

Catalog No. T16709Cas No. 93076-89-2

Alias DKGI-I, Diacylglycerol kinase inhibitor I

R 59-022 (DKGI-I) is a diacylglycerol kinase (DGK) inhibitor and a 5-HT Receptor antagonist that blocks filovirus internalization in host cells. R 59-022 activates protein kinase C (PKC), inhibits intestinal smooth muscle contractility, and enhances O2- production induced by 1-oleoyl-2-acetylglycerol.

R 59-022

🥰Excellent

Catalog No. T16709Alias DKGI-I, Diacylglycerol kinase inhibitor ICas No. 93076-89-2

Pack Size	Price	Availability
1 mg	$32	In Stock
5 mg	$72	In Stock
10 mg	$128	In Stock
25 mg	$298	In Stock
50 mg	$497	In Stock
100 mg	$853	In Stock

Bulk & Custom

Add to Cart

Questions

Select Batch

Resource Download

COA HNMR

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity

Description	R 59-022 (DKGI-I) is a diacylglycerol kinase (DGK) inhibitor and a 5-HT Receptor antagonist that blocks filovirus internalization in host cells. R 59-022 activates protein kinase C (PKC), inhibits intestinal smooth muscle contractility, and enhances O2- production induced by 1-oleoyl-2-acetylglycerol.
Targets&IC50	EBOV GP:~2 µM
In vitro	Vero cells were treated with increasing concentrations of R 59-022 and exposed for 4 hours to MLV pseudotypes encoding LacZ and bearing EBOV GP or VSV-G in the presence of the drug. R 59-022 blocked an entry step specific to EBOV GP. Vero cells were treated with increasing concentrations of R 59-022 and exposed to VLPs bearing EBOV GP or VSV G in the presence of the drug for 3 h. By CCF2-AM staining and flow cytometry analysis, R 59-022 dose-dependent decrease in entry by the VLPs harboring the EBOV GP , IC50: ~2 µM. [5]
Alias	DKGI-I, Diacylglycerol kinase inhibitor I

Chemical Properties

Molecular Weight	459.58
Formula	C₂₇H₂₆FN₃OS
Cas No.	93076-89-2
Smiles	O=C1C(=C(N=C2SC=CN21)C)CCN3CCC(=C(C=4C=CC=CC4)C5=CC=C(F)C=C5)CC3
Relative Density.	1.26g/cm3

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Solubility Information

DMSO: 50 mg/mL (108.79 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.1759 mL	10.8795 mL	21.7590 mL	108.7950 mL
5 mM	0.4352 mL	2.1759 mL	4.3518 mL	21.7590 mL
10 mM	0.2176 mL	1.0879 mL	2.1759 mL	10.8795 mL
20 mM	0.1088 mL	0.5440 mL	1.0879 mL	5.4397 mL
50 mM	0.0435 mL	0.2176 mL	0.4352 mL	2.1759 mL
100 mM	0.0218 mL	0.1088 mL	0.2176 mL	1.0879 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc